|
RECOMBINANT ANTIBODIES | ||||
Cambridge Healthtech Institute
, Baltimore, Maryland June 5-6, 2000 |
||||
Antibody therapeutics hold the promise of effective treatment for some of the most significant unmet clinical needs, including cancer, HIV, autoimmune diseases, infectious disease, neuromuscular disease, vascular disease, organ rejection, and allergic disease. Research is revealing more about the basic science of antibodies and their use as powerful therapeutics. This conference will present the latest data on topics relating to recombinant antibodies and their potential in the treatment of disease. It will also explore the latest results from pre-clinical and clinical trials of antibody-based therapeutics. |
||||
Organized by: |
Cambridge Healthtech Institute |
|||
Deadline for Abstracts: |
April 28, 2000 |
|||
Registration: |
||||
Email for Requests and Registration: | jlaakso@healthtech.com | |||
Posted by: Jennifer Laakso Host: 140.239.39.137 date: January 20, 2000 15:30:37 Generated by meetings and positions 2.0 by Kai Garlipp Logo and Logo Images by Art for BioMed / Syrinx GmbH - Frankfurt / Germany. 4.1 (c) 1995-99 HUM-MOLGEN. All rights reserved. Liability and Copyright. |